Risk assessment of systemic sclerosis-associated pulmonary arterial hypertension: cardiac index versus stroke volume index

Pulmonary arterial hypertension (PAH) frequently complicates systemic sclerosis (SSc), with an estimated prevalence of 6.4–9% [1, 2]. Although survival has improved with the advent of PAH-specific therapy, SSc-PAH continues to have poor prognosis, with a 3-year survival of 67% [3]. Current PAH management guidelines highlight the importance of risk stratification in guiding therapy [4].

Source: European Respiratory Journal - September 15, 2022 Category: Respiratory Medicine Authors: Hassan, H. J., Naranjo, M., Kazzi, B., Housten-Harris, T., Hsu, S., Balasubramanian, A., Simpson, C. E., Damico, R. L., Kolb, T. M., Mathai, S. C., Hassoun, P. M. Tags: Research letters Source Type: research